Allogeneic hematopoietic stem cell transplantation is associated with improved survival compared with chemotherapy in patients with acute myeloid leukemia harboring favorable-risk genetic features at initial diagnosis: a single-center retrospective study
Rujiao Dong, Lihua Wu, Chunling Zhao, Xianling Chen, Xiaohong Yuan, Zhijuan Zhu, Xiaofan Li, Nainong Li · 2026
Read Allogeneic hematopoietic stem cell transplantation is associated with improved survival compared with chemotherapy in patients with acute myeloid leukemia harboring favorable-risk genetic features at initial diagnosis: a single-center retrospective study by Rujiao Dong, Lihua Wu, Chunling Zhao, Xianling Chen, Xiaohong Yuan, Zhijuan Zhu, Xiaofan Li, Nainong Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619477.txt.
Description
Rujiao Dong and co-authors compare stem cell transplant with chemotherapy for a favorable-risk form of acute myeloid leukemia, in a 2026 study. Patients with this genetic profile often reach remission on chemotherapy alone. What to do next, more chemotherapy or a transplant from a donor, is still debated. The team look back at cases from one hospital to weigh the two paths.
They reviewed 190 patients treated between 2012 and 2022. One group, 118 patients, stayed on chemotherapy after induction. The other, 72 patients, went on to donor transplant. The team compared overall survival, time free of leukemia, relapse rates, and deaths not caused by relapse. The title states their main finding: transplant was linked with better survival in this group.
Catalog record
| CREATOR | Rujiao Dong, Lihua Wu, Chunling Zhao, Xianling Chen, Xiaohong Yuan, Zhijuan Zhu, Xiaofan Li, Nainong Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |